Titanium IBR LP

Bovine Rhinotracheitis Vaccine

Modified Live Virus

Leptospira Pomona Bacterin

from the Signature cell line^®

IBR-LP

Titanium IBR LP Indications

For the vaccination of healthy cattle as an aid in the prevention of disease caused by bovine rhinotracheitis virus (IBR) and Leptospira pomona.

DIRECTIONS AND DOSAGE: Rehydrate the desiccated vial with accompanying diluent and shake well. Inject 2 mL subcutaneously or intramuscularly using aseptic technique. Annual revaccination is recommended. Calves vaccinated before weaning should be revaccinated 30 days after weaning when the possible influence of maternal antibodies is decreased.

Titanium IBR LP Caution

Store at 35° to 46° F (2° to 8° C). DO NOT FREEZE. Use entire contents when first opened. Allergic reactions may follow the use of vaccines; ANTIDOTE: Epinephrine. Do not vaccinate within 21 days before slaughter. Burn container and all unused contents. Contains thimerosal as a preservative.

DO NOT USE IN PREGNANT COWS OR IN CALVES NURSING PREGNANT COWS. ABORTIONS MAY RESULT.

FOR USE IN ANIMALS ONLY

Elanco, Titanium and the diagonal bar are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries or affiliates.

Manufactured by: Diamond Animal Health, Inc., Des Moines, Iowa 50327 U.S.A.

U.S. Veterinary License No. 213

Distributed by: Elanco Animal Health, Greenfield, IN 46140 U.S.A., A Division of Eli Lilly and Company

1-800-428-4441

CPN: 1031067.0